Literature DB >> 15671307

Disease expression in Usher syndrome caused by VLGR1 gene mutation (USH2C) and comparison with USH2A phenotype.

Sharon B Schwartz1, Tomas S Aleman, Artur V Cideciyan, Elizabeth A M Windsor, Alexander Sumaroka, Alejandro J Roman, Tej Rane, Elaine E Smilko, Jean Bennett, Edwin M Stone, William J Kimberling, Xue-Zhong Liu, Samuel G Jacobson.   

Abstract

PURPOSE: To investigate the retinal disease expression in USH2C, the subtype of Usher syndrome type 2 recently shown to be caused by mutation in the VLGR1 gene, and compare results with those from USH2A, a more common cause of Usher syndrome.
METHODS: Three siblings with USH2C and 14 patients with USH2A were studied. Visual function was measured by kinetic perimetry, static chromatic perimetry, and electroretinography (ERG). Central retinal microstructure was studied with optical coherence tomography (OCT).
RESULTS: The siblings with VLGR1 mutation showed abnormal photoreceptor-mediated function in all retinal regions, and there was greater rod than cone dysfunction. USH2A had a wider spectrum of disease expression and included patients with normal function in some retinal regions. When abnormalities were detected, there was more rod than cone dysfunction. Retinal microstructure in both USH2C and USH2A shared the abnormality of loss of outer nuclear layer thickness. Central retinal structure in both genotypes was complicated by cystic macular lesions. A coincidental finding in an USH2C patient was that oral intake of antihistamines was associated with temporary resolution of the macular cystic change.
CONCLUSIONS: USH2C and USH2A manifest photoreceptor disease with rod- and cone-mediated visual losses and thinning of the outer nuclear layer. An orderly progression through disease stages was estimated from cross-sectional and limited longitudinal data. Intrafamilial and interfamilial variation in retinal severity in USH2A, however, suggests that genetic or nongenetic modifiers may be involved in the disease expression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15671307     DOI: 10.1167/iovs.04-1136

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  24 in total

1.  Cone responses in Usher syndrome types 1 and 2 by microvolt electroretinography.

Authors:  Wadih M Zein; Benedetto Falsini; Ekaterina T Tsilou; Amy E Turriff; Julie M Schultz; Thomas B Friedman; Carmen C Brewer; Christopher K Zalewski; Kelly A King; Julie A Muskett; Atteeq U Rehman; Robert J Morell; Andrew J Griffith; Paul A Sieving
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-11-25       Impact factor: 4.799

2.  PDZD7 is a modifier of retinal disease and a contributor to digenic Usher syndrome.

Authors:  Inga Ebermann; Jennifer B Phillips; Max C Liebau; Robert K Koenekoop; Bernhard Schermer; Irma Lopez; Ellen Schäfer; Anne-Francoise Roux; Claudia Dafinger; Antje Bernd; Eberhart Zrenner; Mireille Claustres; Bernardo Blanco; Gudrun Nürnberg; Peter Nürnberg; Rebecca Ruland; Monte Westerfield; Thomas Benzing; Hanno J Bolz
Journal:  J Clin Invest       Date:  2010-05-03       Impact factor: 14.808

3.  The very large G-protein-coupled receptor VLGR1: a component of the ankle link complex required for the normal development of auditory hair bundles.

Authors:  Joann McGee; Richard J Goodyear; D Randy McMillan; Eric A Stauffer; Jeffrey R Holt; Kirsten G Locke; David G Birch; P Kevin Legan; Perrin C White; Edward J Walsh; Guy P Richardson
Journal:  J Neurosci       Date:  2006-06-14       Impact factor: 6.167

4.  Retinal disease course in Usher syndrome 1B due to MYO7A mutations.

Authors:  Samuel G Jacobson; Artur V Cideciyan; Dan Gibbs; Alexander Sumaroka; Alejandro J Roman; Tomas S Aleman; Sharon B Schwartz; Melani B Olivares; Robert C Russell; Janet D Steinberg; Margaret A Kenna; William J Kimberling; Heidi L Rehm; David S Williams
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-07       Impact factor: 4.799

5.  A mutation in Myo15 leads to Usher-like symptoms in LEW/Ztm-ci2 rats.

Authors:  Nadine Held; Bart M G Smits; Roland Gockeln; Stephanie Schubert; Heike Nave; Emily Northrup; Edwin Cuppen; Hans J Hedrich; Dirk Wedekind
Journal:  PLoS One       Date:  2011-03-29       Impact factor: 3.240

6.  Mutation analysis in the long isoform of USH2A in American patients with Usher Syndrome type II.

Authors:  Denise Yan; Xiaomei Ouyang; D Michael Patterson; Li Lin Du; Samuel G Jacobson; Xue-Zhong Liu
Journal:  J Hum Genet       Date:  2009-10-30       Impact factor: 3.172

7.  A large deletion in GPR98 causes type IIC Usher syndrome in male and female members of an Iranian family.

Authors:  N Hilgert; K Kahrizi; N Dieltjens; N Bazazzadegan; H Najmabadi; R J H Smith; G Van Camp
Journal:  J Med Genet       Date:  2009-04       Impact factor: 6.318

8.  Inner retinal abnormalities in X-linked retinitis pigmentosa with RPGR mutations.

Authors:  Tomas S Aleman; Artur V Cideciyan; Alexander Sumaroka; Sharon B Schwartz; Alejandro J Roman; Elizabeth A M Windsor; Janet D Steinberg; Kari Branham; Mohammad Othman; Anand Swaroop; Samuel G Jacobson
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-10       Impact factor: 4.799

9.  Intervisit variability of visual parameters in Leber congenital amaurosis caused by RPE65 mutations.

Authors:  Alejandro J Roman; Artur V Cideciyan; Sharon B Schwartz; Melani B Olivares; Elise Heon; Samuel G Jacobson
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-02-15       Impact factor: 4.799

10.  Harmonin in the murine retina and the retinal phenotypes of Ush1c-mutant mice and human USH1C.

Authors:  David S Williams; Tomas S Aleman; Concepción Lillo; Vanda S Lopes; Louise C Hughes; Edwin M Stone; Samuel G Jacobson
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-03-25       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.